HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

7- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamide

a histone deacetylase inhibitor; structure in first source
Also Known As:
CUDC 101; CUDC-101; CUDC101
Networked: 20 relevant articles (1 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wang, Jing: 6 articles (04/2015 - 03/2010)
2. Atoyan, Ruzanna: 3 articles (04/2015 - 05/2010)
3. Cai, Xiong: 3 articles (06/2013 - 03/2010)
4. Lai, Cheng-Jung: 3 articles (06/2013 - 03/2010)
5. Ji, Meiying: 2 articles (01/2021 - 01/2018)
6. Boufraqech, Myriem: 2 articles (03/2016 - 04/2015)
7. Kebebew, Electron: 2 articles (03/2016 - 04/2015)
8. Zhang, Lisa: 2 articles (03/2016 - 04/2015)
9. Ma, Anna W: 2 articles (04/2015 - 06/2013)
10. Voi, Maurizio: 2 articles (10/2014 - 06/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Squamous Cell Carcinoma of Head and Neck
3. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
4. Leukemia
5. Acute Promyelocytic Leukemia

Related Drugs and Biologics

1. Histone Deacetylase Inhibitors
2. Gemcitabine
3. Caspases
4. Proteins (Proteins, Gene)
5. Hydroxamic Acids (Hydroxamic Acid)
6. Vorinostat
7. Retinoic Acid Receptor alpha
8. CUDC-907
9. givinostat
10. resminostat

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Drug Therapy (Chemotherapy)